NCT06957691
- Conditions
- Adenocarcinoma, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen Deprivation Therapy, +40 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Prostate Cancer Recurrent. Study availability and eligibility vary by location and protocol.
NCT06957691
NCT07690579
NCT06508567
NCT05036226
NCT07004582
NCT07131956
NCT05352178
NCT05646550
NCT06220188
NCT05022914